Unmasking ‘invisible’ drug trials

June 14, 2013

Publish your data, or else we will—that’s the stark warning to drug companies in a new proposal released today. Peter Doshi, a postdoctoral fellow at Johns Hopkins University in Baltimore, Maryland, and his colleagues are fed up that only about half of all clinical trials are published. They want to change that, by convincing researchers and journals to print data that have been publicly released through other means, such as litigation and Freedom of Information Act requests, but, practically speaking, are sitting dormant in the filing cabinets or computers of individual scientists. (Science)